One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)

EuroIntervention 2017;13:424-431 published online ahead of print May 2017. DOI: 10.4244/EIJ-D-17-00246

Luca Testa
Luca Testa1*, MD; Marco De Carlo2, MD; Alessandro Petrolini3, MD; Claudio Rapetto4, MD; Ferdinando Varbella5, MD; Bernardo Cortese6, MD; Gabriele Gabrielli7, MD; Salvatore Geraci8, MD; Bruno Loi9, MD; Giacomo Boccuzzi10, MD; Giuseppe Tarantini11, MD; Dionigi Fischetti12, MD; Paolo Calabria13, MD; Fabrizio Tomai3, MD; Flavio Ribichini14, MD; Corrado Tamburino15, MD; Ciro Indolfi16, MD; Antonio L. Bartorelli17, MD; Anna Sonia Petronio2
1. Department of Cardiology, IRCCS Policlinico S. Donato, Milan, Italy; 2. Department of Clinical and Experimental Medicine, University of Pisa, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 3. Department o

Aims: The present multicentre prospective study, IT-DISAPPEARS, was designed with the aim of evaluating early and long-term clinical outcomes of the Absorb BVS in patients with long coron

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bioresorbable scaffoldsdiffuse diseasemultivessel disease
Coronary interventionsStents and scaffolds
Read next article
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

Latest news